Free Trial

UiPath, Inc. (NYSE:PATH) CEO Sells $592,650.00 in Stock

UiPath logo with Computer and Technology background

UiPath, Inc. (NYSE:PATH - Get Free Report) CEO Daniel Dines sold 45,000 shares of the business's stock in a transaction dated Wednesday, July 9th. The stock was sold at an average price of $13.17, for a total value of $592,650.00. Following the completion of the sale, the chief executive officer directly owned 5,283,376 shares of the company's stock, valued at $69,582,061.92. This represents a 0.84% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Daniel Dines also recently made the following trade(s):

  • On Monday, July 7th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $13.11, for a total value of $589,950.00.
  • On Wednesday, July 2nd, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.54, for a total value of $564,300.00.
  • On Monday, June 30th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.78, for a total value of $575,100.00.
  • On Friday, June 27th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.78, for a total value of $575,100.00.
  • On Wednesday, June 25th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.55, for a total value of $564,750.00.
  • On Monday, June 23rd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.10, for a total value of $544,500.00.

UiPath Stock Performance

Shares of PATH stock traded down $0.43 during trading on Thursday, hitting $12.90. The company had a trading volume of 6,109,749 shares, compared to its average volume of 10,309,283. The firm has a market capitalization of $6.90 billion, a P/E ratio of -107.47, a price-to-earnings-growth ratio of 17.46 and a beta of 1.04. The stock's 50-day moving average price is $12.71 and its 200 day moving average price is $12.48. UiPath, Inc. has a one year low of $9.38 and a one year high of $15.93.

UiPath (NYSE:PATH - Get Free Report) last released its earnings results on Thursday, May 29th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.01. The firm had revenue of $356.62 million during the quarter, compared to analysts' expectations of $332.17 million. UiPath had a negative return on equity of 3.05% and a negative net margin of 4.65%. The company's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.13 earnings per share. On average, research analysts anticipate that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.

Institutional Trading of UiPath

A number of institutional investors and hedge funds have recently bought and sold shares of PATH. Wealth Enhancement Advisory Services LLC lifted its position in UiPath by 85.3% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 229,471 shares of the company's stock valued at $3,050,000 after acquiring an additional 105,633 shares in the last quarter. Sivia Capital Partners LLC bought a new position in UiPath in the 2nd quarter valued at about $169,000. Pallas Capital Advisors LLC lifted its position in UiPath by 24.8% in the 2nd quarter. Pallas Capital Advisors LLC now owns 105,834 shares of the company's stock valued at $1,355,000 after acquiring an additional 21,058 shares in the last quarter. Krilogy Financial LLC bought a new position in UiPath in the 2nd quarter valued at about $326,000. Finally, Juncture Wealth Strategies LLC bought a new position in UiPath in the 2nd quarter valued at about $145,000. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Evercore ISI upped their price objective on UiPath from $11.00 to $15.00 and gave the company an "in-line" rating in a research note on Friday, May 30th. Scotiabank boosted their target price on UiPath from $12.00 to $13.00 and gave the stock a "sector perform" rating in a report on Friday, May 30th. Barclays restated an "equal weight" rating on shares of UiPath in a research report on Friday, May 30th. DA Davidson raised UiPath to a "hold" rating in a report on Monday, June 9th. Finally, Wells Fargo & Company reaffirmed an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $13.83.

View Our Latest Stock Report on PATH

About UiPath

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

See Also

Insider Buying and Selling by Quarter for UiPath (NYSE:PATH)

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines